A double-blind, placebo-controlled trial of the thromboxane synthetase blocker OKY-046 on bronchial hypersensitivity in bronchial asthma patients

Journal of Asthma

Volumn 35, Issue 4, 1998, Pages 355-360

  Kunitoh, Hideo ^a,c   Watanabe, Koshiro ^a   Nagatomo, Akira ^a   Okamoto, Hiroaki ^a   Nakagawa, Takemasa ^b  

^a YOKOHAMA MUNICIPAL CITIZEN'S HOSPITAL   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Asthma; Bronchial hyperresponsiveness; OKY 046; Synthetase blocker; Thromboxane

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; METHACHOLINE; OZAGREL; THROMBOXANE B2; THROMBOXANE SYNTHASE INHIBITOR;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; BRONCHUS REACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE;

EID: 0031731034     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.3109/02770909809075668     Document Type: Article

References (25)

1. American Thoracic Society: Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 136:225-244 (1987).
2. Boushey HA, Holzman MJ, Scheller JR, Nadal LA: Bronchial hyperreactivity. Am Rev Respir Dis 121:384-413 (1980).
3. Chai, H, Farr RS, Froehlick LA, Mathison DA, McLean JA, Rosenthal RR, Sheffer AL, Spector SL, Townley RG: Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 56:323-327 (1975).
4. Orehek J, Gayrard P, Smith AP, Grimaud C, Charpin J: Airway response to carbochol in normal and asthmatic subjects: distinction between bronchial sensitivity and reactivity. Am Rev Respir Dis 115:937-943 (1977).
5. 2: effects on airway and vascular smooth muscle. Prostaglandins 14:425-436 (1977).
6. Wenzel SE, Westcott JY, Smith HR, Larsen G: Spectrum of prostanoid release after bronchoalveolar allergen challenge in atopic asthmatic and in control groups. Am Rev Respir Dis 139:450-457 (1989).
7. Aizawa H, Chung KF, Leikauf GD, Ueki I, Bethel RA, O'Byrne PM, Hirose T, Nadel JA: Significance of thromboxane generation in ozone-induced airway hyperresponsiveness in dogs. J Appl Physiol 59:1918-1923 (1985).
8. 2) in guinea pigs. J Asthma 26:237-242 (1989).
9. 2 in the pathogenesis of airway hyperresponsiveness. Eur Respir J 2:782-786 (1989).
10. Naito J, Komatsu H, Ujiie A, Hamano A, Kubota T, Tsuboshima M: Effects of thromboxane synthetase inhibitors on aggregation of rabbit platelets. Eur J Pharmacol 91:41-48 (1983).
11. Fujimura M, Koshino K, Nishioka S, Matsuda T: Involvement of thromboxane A2 in SRS-A mediated bronchoconstriction induced by aerosol antigen in the guinea pigs. Kokyu to Junkan 3:1066-1071 (1984).
12. 4-induced bronchoconstriction in guinea pigs. Prostaglandins 35:427-437 (1988).
13. Fujimura M, Sasaki F, Nakatsumi Y, Takahashi Y, Hifumi S, Taga K, Mifune J, Tanaka T, Matsuda T: Effects of a thromboxane synthetase inhibitor (OKY-046) and a lipoxygenase inhibitor (AA-861) on bronchial responsiveness to acetylcholine in asthmatic subjects. Thorax 41:955-959 (1986).
14. Fujimura M, Nishioka S, Kumabashiri I, Matsuda T, Mifune J: Effects of aerosol administration of a thromboxane synthetase inhibitor (OKY-046) on bronchial responsiveness to acetylcholine in asthmatic subjects. Chest 98:276-279 (1990).
15. Fujimura M, Sakamoto S, Matsuda T: Attenuating effect of a thromboxane synthetase inhibitor (OKY-046) on bronchial responsiveness to methacholine is specific to bronchial asthma. Chest 98:656-660 (1990).
16. Takishima T, Hida W, Suzuki S, Sasaki T: Direct graphical recordings of the cumulative dose-response curves of the airway to methacholine in normal, bronchitic and asthmatic subjects. Tohoku J Exp Med 135:117-137 (1981).
17. Takishima T, Hida W, Sasaki H, Suzuki S, Sasaki T: Direct-writing recorder of the dose-response curves of the airway to methacholine: clinical application. Chest 80:600-606 (1981).
18. Liu Y-N, Sasaki H, Ishii M, Sekizawa K, Hida W, Ichinose M, Takishima T: Effect of circadian rhythm on bronchomotor tone after deep inspiration in normal and in asthmatic subjects. Am Rev Respir Dis 132:278-282 (1985).
19. Hamberg M, Svensson J, Samuelsson B: Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 72:2994-2998 (1975).
20. 1α in plasma. Drug Res 36:1174-1179 (1986).
21. 2 and prostacycline release in bleeding time blood during primary haemostasis in healthy individuals. Acta Med Scand 223:187-190 (1988).
22. Barnes PJ, Chung KF, Page CP: Inflammatory mediators and asthma. Pharmacol Rev 40:49-84 (1988).
23. Alabaster VA, Moore BA: Drug intervention in asthma: present and future. Thorax 48:176-182 (1993).
24. Hardy C, Robinson C, Lewis RA, Tattersfield AE, Holgate ST: Airway and cardiovascular responses to inhaled prostacyclin in normal and asthmatic subjects. Am Rev Respir Dis 131:18-21 (1985).
25. 2 receptor antagonist (AA-2414) on bronchial hyperresponsiveness to methacholine in subjects with asthma. J Allergy Clin Immunol 87:23-27 (1991).